New York Times · Cade Metz ·

Insilico, which uses AI to accelerate drug discovery, says early data shows rentosertib, a drug whose structure was generated with AI's help, could slow aging

Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition.

In this story Insilico rentosertib

Insilico, which uses AI to accelerate drug discovery, says early data shows rentosertib, a drug whose structure was generated with AI's help, could slow aging

Lead Source

New York Times — Insilico, which uses AI to accelerate drug discovery, says early data shows rentosertib, a drug whose structure was generated with AI's help, could slow aging ↗

How this story grew

Coverage · 0 Discussion · 0

Sep 7Sep 9

More

Nature Biotechnology: Nature Biotechnology

Digital Trends: Digital Trends

Gizmodo: Gizmodo

Bloomberg: Bloomberg

The Decoder: The Decoder

Insilico Medicine: Insilico Medicine

The Next Web: The Next Web

MarketWatch: MarketWatch

Unite.AI: Unite.AI

Wall Street Journal: Wall Street Journal

Discussion

r/accelerate r/technology r/longevity r/immortalists

@andrewaiginin @insilicomeds @davidasinclair @erictopol @biogerontology @naturebiotech @insilicomeds @deryatr_ @daniel_kraft

Related stories

Bloomberg: Forus, which uses AI to help patients get prescribed drugs more quickly by navigating steps like insurance coverage, raised a $150M Series C at a $3B valuation

Dealroom.co: Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32

GamesBeat: Astromech, which uses genomic data to build predictive AI models of biological change, raised $20M at a $3.8B valuation, bringing its total funding to $60M

GeekWire: Resect AI, which is developing open-source tech to catch AI hallucinations before they happen, emerges from stealth with $25M from private equity investors

Wall Street Journal: Network Bio, which is developing an AI foundation model from datasets of patient tissue and blood samples created by pooling access to biobanks, raised $50M

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif